Related Experiment Videos
Toxic hepatitis associated with paroxetine.
O Colakoglu1, E Tankurt, B Unsal
1Gastroenterology Clinics, Ataturk Training and Research Hospital, Izmir, Turkey. ondercl@superonline.com
International Journal of Clinical Practice
|June 21, 2005
Summary
Paroxetine, a common antidepressant, can rarely cause severe liver injury. This case highlights a potential immune-mediated reaction leading to cholestatic and hepatocellular damage.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Immunology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) like paroxetine are widely prescribed for depression.
- While generally safe, rare instances of drug-induced liver injury (DILI) associated with SSRIs have been documented.
- Hepatotoxicity from paroxetine is an uncommon but serious adverse event.
Observation:
- A patient developed severe liver injury while taking paroxetine.
- The injury presented as both cholestatic and hepatocellular patterns.
- Elevated transaminase levels indicated significant hepatic dysfunction.
Findings:
- The observed liver injury was likely an adverse reaction to paroxetine.
- Evidence suggests an immune-mediated hypersensitivity mechanism.
- This case underscores the potential for paroxetine to induce severe hepatotoxicity.
Implications:
- Clinicians should consider paroxetine-induced liver injury in patients presenting with unexplained hepatitis.
- Further investigation into the immunopathogenesis of paroxetine hepatotoxicity may be warranted.
- This case emphasizes the importance of monitoring liver function in patients on SSRIs, especially with prolonged use or concerning symptoms.